Schaefer et al. reported that IRF1 and IRF2 can constitutively activate the promoter of the EBV BamHI Q fragment [43], but whether miR-23a-mediated IRF1 suppression is involved in EBV infection in gastric cancer remains unknown. This evidence concerns the gene IRF1 and gastric cancer.